Literature DB >> 8434333

Principles and history of neutron capture therapy.

W Sauerwein1.   

Abstract

Neutron capture therapy (NCT) is a form of radiation therapy using nuclides having a high propensity for capturing thermal neutrons and reacting with a prompt nuclear reaction (i.e. disintegration). If these nuclides are introduced selectively into tumor cells it is theoretically possible to destroy the tumor and to spare the surrounding normal tissue. The principles of this modality were described in 1936. First clinical trials in the USA from 1951 to 1961 using 10B resulted in failure. Since 1968 patients suffering from glioblastoma have been successfully treated in Japan by NCT with 10B and since 1987 another Japanese group has treated melanoma using NCT. The Japanese experiences and recent advances in the evaluation of tumor-affinitive boron-containing drugs have spurred interest in NCT. This article presents some basic physical notions and a historic overview of NCT that emphasizes the well documented early trials as well as some recent developments. Problems which occurred in the past now demand special efforts for a better understanding of the effects of NCT before starting new clinical trials in the next few years.

Entities:  

Mesh:

Year:  1993        PMID: 8434333     DOI: 10.1007/978-3-642-31334-9_1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  3 in total

Review 1.  Boron neutron capture therapy for glioblastoma multiforme.

Authors:  Catharina M van Rij; Abraham J Wilhelm; Wolfgang A G Sauerwein; Arie C van Loenen
Journal:  Pharm World Sci       Date:  2005-04

2.  Boron uptake in normal melanocytes and melanoma cells and boron biodistribution study in mice bearing B16F10 melanoma for boron neutron capture therapy.

Authors:  Fernanda Faião-Flores; Paulo Rogério Pinto Coelho; João Dias Toledo Arruda-Neto; Maria Aparecida Pires Camillo; Silvya Stuchi Maria-Engler; Rose Eli Grassi Rici; Jorge Eduardo Souza Sarkis; Durvanei Augusto Maria
Journal:  Radiat Environ Biophys       Date:  2012-04-11       Impact factor: 1.925

3.  In Vitro Studies to Define the Cell-Surface and Intracellular Targets of Polyarginine-Conjugated Sodium Borocaptate as a Potential Delivery Agent for Boron Neutron Capture Therapy.

Authors:  Atsushi Fujimura; Seiji Yasui; Kazuyo Igawa; Ai Ueda; Kaori Watanabe; Tadashi Hanafusa; Yasuaki Ichikawa; Sachiko Yoshihashi; Kazuki Tsuchida; Atsunori Kamiya; Shuichi Furuya
Journal:  Cells       Date:  2020-09-23       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.